The Claim
The binding affinity of (125)I-GLP-1(7-36)amide to human tissues exhibits a potency rank order of GLP-1(7-36)amide = exendin-4 >> GLP-2 = glucagon(1-29), which supports the specific identification of GLP-1 receptors in both tumor and normal human tissues.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Scientists used a labeled version of a hormone to see where it sticks in human tissues, and the pattern they found confirms it’s attaching to specific receptors linked to GLP-1 — in both healthy and tumor tissues.
See the scientific wording
The binding of (125)I-GLP-1(7-36)amide to human tissues shows a rank order of potency—GLP-1(7-36)amide = exendin-4 >> GLP-2 = glucagon(1-29)—which confirms specific identification of GLP-1 receptors in both tumor and normal tissues.
What the research says
1 studyStudy: GLP-1 Receptor Expression in Human Tumors and Human Normal Tissues: Potential for In Vivo Targeting
The study shows that a certain substance binds to tissues in a very specific way that proves it's attaching to GLP-1 receptors, just like the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.